Akso Cost Of Revenue from 2010 to 2024
| AHG Stock | USD 0.86 0.02 2.27% |
Cost Of Revenue | First Reported 2016-06-30 | Previous Quarter 427.4 K | Current Value 718.7 K | Quarterly Volatility 2.6 M |
Check Akso Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akso Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 187.4 K, Selling General Administrative of 13.5 M or Selling And Marketing Expenses of 160 K, as well as many indicators such as Price To Sales Ratio of 10.58, Dividend Yield of 0.088 or PTB Ratio of 0.18. Akso financial statements analysis is a perfect complement when working with Akso Health Valuation or Volatility modules.
Akso | Cost Of Revenue |
Latest Akso Health's Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of Akso Health Group over the last few years. Cost of Revenue is found on Akso Health Group income statement and represents the costs associated with goods and services Akso Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Akso Health's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Akso Health's overall financial position and show how it may be relating to other accounts over time.
| Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
| Timeline |
Akso Cost Of Revenue Regression Statistics
| Arithmetic Mean | 3,916,319 | |
| Geometric Mean | 2,862,709 | |
| Coefficient Of Variation | 83.03 | |
| Mean Deviation | 2,646,060 | |
| Median | 2,292,206 | |
| Standard Deviation | 3,251,864 | |
| Sample Variance | 10.6T | |
| Range | 11.4M | |
| R-Value | 0.39 | |
| Mean Square Error | 9.7T | |
| R-Squared | 0.15 | |
| Significance | 0.15 | |
| Slope | 282,677 | |
| Total Sum of Squares | 148T |
Akso Cost Of Revenue History
About Akso Health Financial Statements
Akso Health stakeholders use historical fundamental indicators, such as Akso Health's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Akso Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akso Health's assets and liabilities are reflected in the revenues and expenses on Akso Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akso Health Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 2.3 M | 2.2 M |
Currently Active Assets on Macroaxis
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:Check out the analysis of Akso Health Correlation against competitors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share 0.051 | Quarterly Revenue Growth 0.148 | Return On Assets (0.07) | Return On Equity (0.12) |
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.